193156-92-2

Upstream product

• 193156-89-7 2-(2,3,4,6-tetra-O-acetylated-1-deoxy-α-D-galactopyranosyl)-ethanoic acid 
• 193156-91-1 [2-((2R,3S,4R,5S,6R)-3,4,5-Triacetoxy-6-acetoxymethyl-tetrahydro-pyran-2-yl)-ethylamino]-acetic acid benzyl ester 
• 1738-68-7 Gly-OBz 
• 4163-60-4 β-D-galactose peracetate 
• 53263-18-6 allyl 2,3,4,6-tetra-O-acetyl-α-D-galactopyranoside 
• 193156-88-6 2-(2,3,4,6-tetra-O-acetyl-α-D-galactopyranosyl)acetaldehyde 

Downstream Products

• 193156-85-3 C₆₄H₇₈N₄O₂₅ 
• 261724-19-0 4-(2-{[2-((2R,3S,4R,5S,6R)-3,4,5-Triacetoxy-6-acetoxymethyl-tetrahydro-pyran-2-yl)-acetyl]-[2-((2R,3S,4R,5S,6R)-3,4,5-triacetoxy-6-acetoxymethyl-tetrahydro-pyran-2-yl)-ethyl]-amino}-acetylamino)-benzoic acid 
• 261724-38-3 4-(2-{[2-((2R,3S,4R,5S,6R)-3,4,5-Triacetoxy-6-acetoxymethyl-tetrahydro-pyran-2-yl)-acetyl]-[2-((2R,3S,4R,5S,6R)-3,4,5-triacetoxy-6-acetoxymethyl-tetrahydro-pyran-2-yl)-ethyl]-amino}-acetylamino)-benzoic acid benzyl ester 

Relevant academic research and scientific papers

α-Galactose based neoglycopeptides. Inhibition of verotoxin binding to globotriosylceramide

Solution and solid phase strategies for the synthesis of α-galactose based neoglycopeptide derivatives 2-13 were developed. Neoglycopeptides generated were tested for the inhibition of verotoxin binding to globotriosylceramide (Gb3) using ELISA. Among all

Stereoselective synthesis of neo-C-glycopeptide building blocks: Towards a flexible and control-oriented design as probes for carbohydrate-protein interactions

Neo-C-glycopeptides (1-4) have been synthesized as building blocks to obtain higher neo-C-glycopeptides as probes for studying carbohydrate-protein interactions. A convergent approach for the synthesis of 4 has been developed, in which two galactose units are attached to a glycine derivative in a stepwise procedure (reductive amination followed by amide coupling) and finally coupling to the protected dipeptide having a free amino group on the side chain.